<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>3 | Bruggen lab @ University of Zurich</title><link>https://Bruggenlab.github.io/publication-type/3/</link><atom:link href="https://Bruggenlab.github.io/publication-type/3/index.xml" rel="self" type="application/rss+xml"/><description>3</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 07 Sep 2022 00:00:00 +0000</lastBuildDate><image><url>https://Bruggenlab.github.io/media/icon_hu1c243663a46ad1ec416cef6d4d5c702f_55418_512x512_fill_lanczos_center_3.png</url><title>3</title><link>https://Bruggenlab.github.io/publication-type/3/</link></image><item><title>Predicting Dupilumab Treatment Outcome in Patients with Primary diffuse Type 2 Chronic Rhinosinusitis.</title><link>https://Bruggenlab.github.io/publication/dupilumabtreatment/</link><pubDate>Wed, 07 Sep 2022 00:00:00 +0000</pubDate><guid>https://Bruggenlab.github.io/publication/dupilumabtreatment/</guid><description/></item><item><title>Vitiligo-like depigmentation in patients treated with checkpoint inhibitors: Clinical characteristics and predictive proteomic patterns.</title><link>https://Bruggenlab.github.io/publication/vld/</link><pubDate>Wed, 07 Sep 2022 00:00:00 +0000</pubDate><guid>https://Bruggenlab.github.io/publication/vld/</guid><description/></item></channel></rss>